期刊文献+

阿昔洛韦致急性肾功能衰竭2例分析及文献复习 被引量:2

Clinical characteristics of patients with acyclovir-induced acute renal failure: a report of two cases and review of literatures
暂未订购
导出
摘要 目的探讨阿昔洛韦致急性肾功能衰竭(acute renal failure,ARF)的一般规律与特点。方法报道2例阿昔洛韦致ARF的临床表现、实验室检查、治疗及转归,并对相关文献进行复习。结果①2例患者均为青年患者,均在用药24h内起病;②临床表现不一,1例以少尿为主要表现,1例以腰痛为主要表现,2例均伴有恶心纳差;③1例予以停用阿昔洛韦、利尿、碱化尿液及营养支持等对症治疗,4d后肾功能恢复正常,1例通过对症治疗联合3次血液透析治疗,11d后痊愈。结论阿昔洛韦致ARF以肾小管内阻塞为主要发病机制,以非少尿型为主,腰痛是其主要的临床表现,非少尿型ARF经对症治疗多呈良性经过,少尿型ARF多需行血液透析治疗,预防的关键在于规范用药。 Objective To investigate the universal law and characteristic of acyclovir-induced ARF. Methods The clini- cal manifestations ,laboratory testing ,treatment and prognosis of the two cases with acyclovir induced ARF were reported retrospec- tively and the related literatures were reviewed. Results ①Two patients were youth, and ARF developed within 24 hours of acy- clovir administration. ②The clinical manifestations of ARF were varied, 1 patient experienced oliguria, l patient accompanied lumbago and all patients represented nausea and inappetence. ③1 patient recovered completely with discontinuation of acyclovir therapy ,diuresis,alkalization of urine and nutritional support in 4 days, the other patient recovered completely with symptomatic treatment and 3 hemodialysis in 11 days. Conclusion Intratubular crystal obstruction might be the main pathogenesis of acyclov- ir-induced ARF. The main type might be oliguric ARF, lumbago might be its primary symptom. The majority patients of nonoliguric ARF would recover after symptomatic treatment. Most patients of oliguric ARF might need hemodialysis, normative usage of acyclo- vir might be the key to prevent ARF.
出处 《四川医学》 CAS 2013年第9期1310-1312,共3页 Sichuan Medical Journal
关键词 阿昔洛韦 急性肾功能衰竭 病例分析 文献复习 acyclovir acute renal failure case analysis literature review
  • 相关文献

参考文献10

  • 1Izzedine H,Launay-Vacher V,Deray G. Antiviral drug-induced nephrotoxicity[J].{H}American Journal of Kidney Disease,2005,(05):804-817.
  • 2李开龙,张建国,何娅妮,王惠民.阿昔洛韦致急性肾功能衰竭1例[J].重庆医学,2003,32(4):458-458. 被引量:13
  • 3王春婷.阿昔洛韦致急性肾功能衰竭及不合理用药分析[J].中国药物警戒,2007,4(5):268-272. 被引量:13
  • 4Vomiero G,Carpenter B,Robb I. Combination of ceftriaxone and acyclovir-an underestimated nephrotoxic potential[J].{H}Pediatric Nephrology,2002,(08):633-637.
  • 5Ye J,Liu Q,Wang C. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3[J].{H}European Journal of pharmaceutical Sciences,2012,(02):341-346.
  • 6陈瑶,赵银,赵玉兰,石跃玲.阿昔洛韦在4种输液中的稳定性考察[J].中国医院药学杂志,2001,21(5):308-309. 被引量:19
  • 7曹志翔.阿昔洛韦静脉滴注致急性肾功能损害[J].药物不良反应杂志,2005,7(1):58-59. 被引量:6
  • 8钟松阳.58例阿昔洛韦不良反应分析[J].中国医院药学杂志,2007,27(6):851-851. 被引量:16
  • 9Dos Santos Mde F,Dos Santos OF,Boim MA. Nephrotoxicity of acyclovir and ganciclovir in rats:evaluation of glomerular hemodynamics[J].{H}Journal of the American Society of Nephrology,1997,(03):361-367.
  • 10Gunness P,Aleksa K,Koren G. Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2):implications for renal tubular transport and acyclovir-induced nephrotoxicity[J].{H}Canadian Journal of Physiology and Pharmacology,2011,(09):675-680.

二级参考文献21

共引文献58

同被引文献16

  • 1Port FK, Eknoyan G. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide [J]. Am J Kidney Dis, 2004, 44(5 Suppl 2): 1-6.
  • 2Zhang G, Han J, Welch E J, et al. LPS stimulates platelet secretion and potentiates platelet aggregation via TLR4/ MyD88 and the cGMP-dependent protein kinase pathway [J]. J Immunol, 2009, 182(12): 7997-8004.
  • 3Koplik EV, Pertsov SS, Kalinichenko LS. Effect of interleukin-ll3 on peripheral blood leukocytes in rats with various behavioral characteristics during acute stress [J]. Bull Exp Biol Med, 2014, 156(4): 435-440.
  • 4MacFarlane AW 4th, Jillab M, Plimack ER, et al. PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection [J]. Cancer Immunol Res, 2014, 2(4): 320-331.
  • 5Celep RB, Unlu BS. Retrospective platelet values measurement. Is it acceptable to discuss? [J]. Eur Rev Med Pharmacol Sci, 2014, 18(7): 1108.
  • 6Artunc Ulkumen B, Pala HG, Calik E, et al. Can mean platelet volume and platelet distrubition width be possible markers for ectopic pregnancy and tubal rupture? (MPV and PDW in ectopic pregnancy) [J]. Pak J Med Sci, 2014, 30(2): 352-355.
  • 7Beyan C, Kaptan K. Deviation from normal values of leukocyte and erythroblast parameters in complete blood count is a messenger for platelet abnormalities [J]. Turk J Haematol, 2014, 31(1): 107-108.
  • 8吴起武,赵萍.窒息新生儿肾功能损害白细胞计数和血小板参数动态观察[J].中国全科医学,2012,15(6):670-671. 被引量:3
  • 9邓梅花,方鹏.艾滋病患者的护理现状及进展[J].医学理论与实践,2013,26(22):2978-2980. 被引量:3
  • 10潘金林,岳菊三,吴耀俊,王坚,聂黎明,林翼金.维持性血液透析患者外周血白细胞计数与颈动脉粥样硬化关系[J].中国全科医学,2013,16(33):3970-3972. 被引量:6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部